WuXi Biologics
WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced it received two…